|Articles|May 11, 2022
- Pharmaceutical Executive-05-01-2022
- Volume 42
- Issue 5
Pharmaceutical Executive, May 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 4 years ago
Restoring Hope in Mental Illness Is a Collective Missionabout 4 years ago
Upward Mobility: Optimizing Your Pharma T-Profileabout 4 years ago
Breadth, Depth, and Enterpriseabout 4 years ago
Rising to the Taskabout 4 years ago
Lessons Learnedabout 4 years ago
Persistence Pays Offabout 4 years ago
Authenticity in Actionabout 4 years ago
Challenging Assumptionsabout 4 years ago
Steady at the ControlsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5